Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
30-day Fidaxomicin for Recurrent C. Difficile Infection
NCT02395848Phase 3Terminated
- Sponsor
- McMaster University
- Start
- Jul 2015
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fidaxomicin in Clostridioides difficile infection (CDI), sponsored by McMaster University. Started Jul 2015; status: terminated.
02
Drugs
fidaxomicin
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02395848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395848.